The University of Delaware is making major strides in the biopharma sector by launching the new SABRE Center. Backed by $45 million in federal funding, including $10 million from the American Rescue Plan, this 90,000-square-foot hub is set to propel the university into a leader in biopharmaceutical
The fusion of synthetic biology (SynBio) with architecture is marking the beginning of a revolutionary shift towards eco-friendly building methods. At the forefront is Ginger Dosier with her pioneering company, Biomason; she represents the future of green construction. SynBio's integration
``` The biopharmaceutical industry is navigating through a phase of spectacular growth, primed to achieve a market valuation of USD 60.3 billion by 2033. This escalation is fuelled by a surge in demand for biopharmaceutical products and the increasingly significant role of Contract Manufacturing
Medical science is on the brink of a transformative breakthrough that promises to redefine pediatric care for children with weakened immune systems. A groundbreaking cell therapy, stemming from a synergistic clinical trial, has emerged as a beacon of hope for young patients threatened by severe
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has recently announced an ambitious new program, Project Call 7.1, to stimulate advancement in biopharmaceutical production and broaden workforce capabilities. With a funding pool of around $10 million, NIIMBL plans
As the pressure mounts to produce food sustainably, advancements in soil technology like BeCrop are critical. Developed by Biome Makers, BeCrop doesn't just analyze soil; it offers a comprehensive picture of the microbial ecosystem that is crucial for soil health and plant growth. With this
The biopharmaceutical sector is experiencing rapid innovation as therapies like monoclonal antibodies and gene treatments push towards market approval. The cornerstone for ensuring their market readiness is rigorous and extensive testing, which is a significant growth factor for the
A Breakthrough in Vaccine Delivery In a revolutionary shift from conventional immunization methods, scientists at Tokyo Medical and Dental University's Uchida Laboratory, along with various prestigious institutions, have created a "naked" mRNA vaccine for SARS-CoV-2. This
Breast cancer remains the most diagnosed cancer among women worldwide, posing significant challenges in terms of early detection, treatment efficacy, and overcoming drug resistance. Among the numerous hurdles faced by patients and oncologists alike is the phenomenon of tamoxifen resistance. As a
In a decisive move to safeguard financial stability and bolster public trust, the United States government has announced a significant intervention in the wake of the Silicon Valley Bank (SVB) failure. Unprecedented Access to Depositor Funds Starting on Monday, former clients of SVB are assured
